【レポートの概要（一部）】
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 8
1.2 List of Figures 18
2 Introduction 19
2.1 Surgical Devices Overview 19
3 Products under Development 20
3.1 Surgical Devices – Pipeline Products by Stage of Development 20
3.2 Surgical Devices – Pipeline Products by Segment 21
3.3 Surgical Devices – Pipeline Products by Territory 23
3.4 Surgical Devices – Pipeline Products by Regulatory Path 24
3.5 Surgical Devices – Pipeline Products by Estimated Approval Date 25
3.6 Surgical Devices – Ongoing Clinical Trials 26
4 Surgical Devices – Pipeline Products under Development by Companies 27
4.1 Surgical Devices Companies – Pipeline Products by Stage of Development 27
4.2 Surgical Devices – Pipeline Products by Stage of Development 32
5 Surgical Devices Companies and Product Overview 37
5.1 Adept Medical Limited Company Overview 37
5.1.1 Adept Medical Limited Pipeline Products & Ongoing Clinical Trials Overview 37
5.2 Anastom Surgical Company Overview 38
5.2.1 Anastom Surgical Pipeline Products & Ongoing Clinical Trials Overview 38
5.3 Apollo Endosurgery, Inc. Company Overview 39
5.3.1 Apollo Endosurgery, Inc. Pipeline Products & Ongoing Clinical Trials Overview 39
5.4 Applied Medical Resources Corporation Company Overview 40
5.4.1 Applied Medical Resources Corporation Pipeline Products & Ongoing Clinical Trials Overview 40
5.5 Arkis BioSciences Company Overview 47
5.5.1 Arkis BioSciences Pipeline Products & Ongoing Clinical Trials Overview 47
5.6 Bio DG Company Overview 49
5.6.1 Bio DG Pipeline Products & Ongoing Clinical Trials Overview 49
5.7 BioTex, Inc. Company Overview 50
5.7.1 BioTex, Inc. Pipeline Products & Ongoing Clinical Trials Overview 50
5.8 Boston Scientific Corporation Company Overview 51
5.8.1 Boston Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview 51
5.9 BriteSeed Company Overview 53
5.9.1 BriteSeed Pipeline Products & Ongoing Clinical Trials Overview 53
5.10 C. R. Bard, Inc. Company Overview 54
5.10.1 C. R. Bard, Inc. Pipeline Products & Ongoing Clinical Trials Overview 54
5.11 Cardica, Inc. Company Overview 56
5.11.1 Cardica, Inc. Pipeline Products & Ongoing Clinical Trials Overview 56
5.12 Carnegie Mellon University Company Overview 65
5.12.1 Carnegie Mellon University Pipeline Products & Ongoing Clinical Trials Overview 65
5.13 CarpoNovum AB Company Overview 67
5.13.1 CarpoNovum AB Pipeline Products & Ongoing Clinical Trials Overview 67
5.14 Castle Surgical, Inc. Company Overview 70
5.14.1 Castle Surgical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 70
5.15 CIVCO Medical Solutions Company Overview 71
5.15.1 CIVCO Medical Solutions Pipeline Products & Ongoing Clinical Trials Overview 71
5.16 Cologuard Ltd Company Overview 73
5.16.1 Cologuard Ltd Pipeline Products & Ongoing Clinical Trials Overview 73
5.17 Control Medical Technology, LLC Company Overview 74
5.17.1 Control Medical Technology, LLC Pipeline Products & Ongoing Clinical Trials Overview 74
5.18 Core Essence Orthopaedics, LLC Company Overview 75
5.18.1 Core Essence Orthopaedics, LLC Pipeline Products & Ongoing Clinical Trials Overview 75
5.19 Cytori Therapeutics, Inc. Company Overview 76
5.19.1 Cytori Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 76
5.20 Ding Hwa Co., Ltd Company Overview 80
5.20.1 Ding Hwa Co., Ltd Pipeline Products & Ongoing Clinical Trials Overview 80
5.21 Embricon Limited Company Overview 81
5.21.1 Embricon Limited Pipeline Products & Ongoing Clinical Trials Overview 81
5.22 EndoEvolution, LLC Company Overview 82
5.22.1 EndoEvolution, LLC Pipeline Products & Ongoing Clinical Trials Overview 82
5.23 Ethicon Endo-Surgery, Inc. Company Overview 83
5.23.1 Ethicon Endo-Surgery, Inc. Pipeline Products & Ongoing Clinical Trials Overview 83
5.24 Eximo Medical Ltd. Company Overview 84
5.24.1 Eximo Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview 84
5.25 Exploit Technologies Pte Ltd Company Overview 85
5.25.1 Exploit Technologies Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview 85
5.26 Fogless International AB Company Overview 86
5.26.1 Fogless International AB Pipeline Products & Ongoing Clinical Trials Overview 86
5.27 Genicon, Inc. Company Overview 87
5.27.1 Genicon, Inc. Pipeline Products & Ongoing Clinical Trials Overview 87
5.28 H. Lee Moffitt Cancer Center & Research Institute, Inc. Company Overview 88
5.28.1 H. Lee Moffitt Cancer Center & Research Institute, Inc. Pipeline Products & Ongoing Clinical Trials Overview 88
5.29 Hadasit Medical Research Services & Development Ltd Company Overview 89
5.29.1 Hadasit Medical Research Services & Development Ltd Pipeline Products & Ongoing Clinical Trials Overview 89
5.30 Hannover Medical School Company Overview 90
5.30.1 Hannover Medical School Pipeline Products & Ongoing Clinical Trials Overview 90
5.31 Harvard University Company Overview 92
5.31.1 Harvard University Pipeline Products & Ongoing Clinical Trials Overview 92
5.32 HemCon Medical Technologies, Inc. Company Overview 94
5.32.1 HemCon Medical Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 94
5.33 Hospital for Special Surgery Company Overview 95
5.33.1 Hospital for Special Surgery Pipeline Products & Ongoing Clinical Trials Overview 95
5.34 i360medical Limited Company Overview 97
5.34.1 i360medical Limited Pipeline Products & Ongoing Clinical Trials Overview 97
5.35 Insightra Medical Inc. Company Overview 98
5.35.1 Insightra Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview 98
5.36 Intuitive Surgical, Inc. Company Overview 102
5.36.1 Intuitive Surgical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 102
5.37 Inx Medical LLC Company Overview 106
5.37.1 Inx Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 106
5.38 IonMed Ltd. Company Overview 107
5.38.1 IonMed Ltd. Pipeline Products & Ongoing Clinical Trials Overview 107
5.39 IPI Singapore Company Overview 111
5.39.1 IPI Singapore Pipeline Products & Ongoing Clinical Trials Overview 111
5.40 Janus Development Group, Inc Company Overview 112
5.40.1 Janus Development Group, Inc Pipeline Products & Ongoing Clinical Trials Overview 112
5.41 Keren Medical Ltd. Company Overview 113
5.41.1 Keren Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview 113
5.42 Kytogenics Pharmaceuticals, Inc. Company Overview 115
5.42.1 Kytogenics Pharmaceuticals, Inc. Pipeline Products & Ongoing Clinical Trials Overview 115
5.43 Lumenis Ltd. Company Overview 116
5.43.1 Lumenis Ltd. Pipeline Products & Ongoing Clinical Trials Overview 116
5.44 MagniFeel Surgical Instruments Company Overview 118
5.44.1 MagniFeel Surgical Instruments Pipeline Products & Ongoing Clinical Trials Overview 118
5.45 Mayo Clinic. Company Overview 119
5.45.1 Mayo Clinic. Pipeline Products & Ongoing Clinical Trials Overview 119
5.46 Mecmaan Healthcare Ltd Company Overview 123
5.46.1 Mecmaan Healthcare Ltd Pipeline Products & Ongoing Clinical Trials Overview 123
5.47 Medical University of South Carolina Company Overview 125
5.47.1 Medical University of South Carolina Pipeline Products & Ongoing Clinical Trials Overview 125
5.48 Medisse BV Company Overview 126
5.48.1 Medisse BV Pipeline Products & Ongoing Clinical Trials Overview 126
5.49 Medivur Company Overview 127
5.49.1 Medivur Pipeline Products & Ongoing Clinical Trials Overview 127
5.50 Medtronic plc Company Overview 128
5.50.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 128
5.51 Memorial Sloan Kettering Cancer Center Company Overview 132
5.51.1 Memorial Sloan Kettering Cancer Center Pipeline Products & Ongoing Clinical Trials Overview 132
5.52 Mercy Research and Development Company Overview 134
5.52.1 Mercy Research and Development Pipeline Products & Ongoing Clinical Trials Overview 134
5.53 Naviswiss AG Company Overview 135
5.53.1 Naviswiss AG Pipeline Products & Ongoing Clinical Trials Overview 135
5.54 NIH Office of Technology Transfer Company Overview 136
5.54.1 NIH Office of Technology Transfer Pipeline Products & Ongoing Clinical Trials Overview 136
5.55 Nitinol Devices and Components, Inc. Company Overview 138
5.55.1 Nitinol Devices and Components, Inc. Pipeline Products & Ongoing Clinical Trials Overview 138
5.56 NorthShore University Health System Company Overview 140
5.56.1 NorthShore University Health System Pipeline Products & Ongoing Clinical Trials Overview 140
5.57 NOvate Medical Technologies, LLC Company Overview 141
5.57.1 NOvate Medical Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview 141
5.58 NovoGI LTD Company Overview 142
5.58.1 NovoGI LTD Pipeline Products & Ongoing Clinical Trials Overview 142
5.59 Novolock Ltd Company Overview 144
5.59.1 Novolock Ltd Pipeline Products & Ongoing Clinical Trials Overview 144
5.60 Olympus Medical Systems Corp. Company Overview 145
5.60.1 Olympus Medical Systems Corp. Pipeline Products & Ongoing Clinical Trials Overview 145
5.61 Parker Hannifin Corporation Company Overview 146
5.61.1 Parker Hannifin Corporation Pipeline Products & Ongoing Clinical Trials Overview 146
5.62 Physcient, Inc. Company Overview 148
5.62.1 Physcient, Inc. Pipeline Products & Ongoing Clinical Trials Overview 148
5.63 POP Medical Solutions Company Overview 152
5.63.1 POP Medical Solutions Pipeline Products & Ongoing Clinical Trials Overview 152
5.64 Pro-Dex, Inc. Company Overview 155
5.64.1 Pro-Dex, Inc. Pipeline Products & Ongoing Clinical Trials Overview 155
5.65 Queen Mary University of London Company Overview 158
5.65.1 Queen Mary University of London Pipeline Products & Ongoing Clinical Trials Overview 158
5.66 Ratner BioMedical Inc. Company Overview 159
5.66.1 Ratner BioMedical Inc. Pipeline Products & Ongoing Clinical Trials Overview 159
5.67 Resultados y Calidad del Sistema Sanitario Publico de Andalucia Company Overview 160
5.67.1 Resultados y Calidad del Sistema Sanitario Publico de Andalucia Pipeline Products & Ongoing Clinical Trials Overview 160
5.68 Sanovas, Inc. Company Overview 164
5.68.1 Sanovas, Inc. Pipeline Products & Ongoing Clinical Trials Overview 164
5.69 simedeq Company Overview 166
5.69.1 simedeq Pipeline Products & Ongoing Clinical Trials Overview 166
5.70 Simon Fraser University Company Overview 167
5.70.1 Simon Fraser University Pipeline Products & Ongoing Clinical Trials Overview 167
5.71 SRI International Company Overview 168
5.71.1 SRI International Pipeline Products & Ongoing Clinical Trials Overview 168
5.72 StatLink Surgical Company Overview 169
5.72.1 StatLink Surgical Pipeline Products & Ongoing Clinical Trials Overview 169
5.73 Stepwise Ltd Company Overview 170
5.73.1 Stepwise Ltd Pipeline Products & Ongoing Clinical Trials Overview 170
5.74 Surgical Energetics LLC Company Overview 171
5.74.1 Surgical Energetics LLC Pipeline Products & Ongoing Clinical Trials Overview 171
5.75 SurgyAid, LLC Company Overview 172
5.75.1 SurgyAid, LLC Pipeline Products & Ongoing Clinical Trials Overview 172
5.76 Synaptive Medical Inc. Company Overview 173
5.76.1 Synaptive Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview 173
5.77 Teleflex Incorporated Company Overview 174
5.77.1 Teleflex Incorporated Pipeline Products & Ongoing Clinical Trials Overview 174
5.78 Tepha, Inc. Company Overview 176
5.78.1 Tepha, Inc. Pipeline Products & Ongoing Clinical Trials Overview 176
5.79 TeVido BioDevices, LLC Company Overview 177
5.79.1 TeVido BioDevices, LLC Pipeline Products & Ongoing Clinical Trials Overview 177
5.80 The Feinstein Institute for Medical Research Company Overview 178
5.80.1 The Feinstein Institute for Medical Research Pipeline Products & Ongoing Clinical Trials Overview 178
5.81 The Johns Hopkins University Company Overview 180
5.81.1 The Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 180
5.82 The University of Utah Company Overview 181
5.82.1 The University of Utah Pipeline Products & Ongoing Clinical Trials Overview 181
5.83 TransEnterix, Inc. Company Overview 182
5.83.1 TransEnterix, Inc. Pipeline Products & Ongoing Clinical Trials Overview 182
5.84 Trinity College Dublin Company Overview 183
5.84.1 Trinity College Dublin Pipeline Products & Ongoing Clinical Trials Overview 183
5.85 Univalue Valorizacion, S.L. Company Overview 184
5.85.1 Univalue Valorizacion, S.L. Pipeline Products & Ongoing Clinical Trials Overview 184
5.86 Universitat Politecnica de Catalunya Company Overview 185
5.86.1 Universitat Politecnica de Catalunya Pipeline Products & Ongoing Clinical Trials Overview 185
5.87 University of Florida Company Overview 187
5.87.1 University of Florida Pipeline Products & Ongoing Clinical Trials Overview 187
5.88 University of Louisville Company Overview 188
5.88.1 University of Louisville Pipeline Products & Ongoing Clinical Trials Overview 188
5.89 University of Minnesota Company Overview 190
5.89.1 University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview 190
5.90 University of New Mexico Company Overview 191
5.90.1 University of New Mexico Pipeline Products & Ongoing Clinical Trials Overview 191
5.91 University of North Carolina Company Overview 192
5.91.1 University of North Carolina Pipeline Products & Ongoing Clinical Trials Overview 192
5.92 University of South Florida Company Overview 193
5.92.1 University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 193
5.93 University of Texas at Austin Company Overview 204
5.93.1 University of Texas at Austin Pipeline Products & Ongoing Clinical Trials Overview 204
5.94 University of Texas Medical Branch at Galveston Company Overview 206
5.94.1 University of Texas Medical Branch at Galveston Pipeline Products & Ongoing Clinical Trials Overview 206
5.95 University of Virginia Company Overview 209
5.95.1 University of Virginia Pipeline Products & Ongoing Clinical Trials Overview 209
5.96 University of Washington Company Overview 210
5.96.1 University of Washington Pipeline Products & Ongoing Clinical Trials Overview 210
5.97 University of Wisconsin Madison Company Overview 211
5.97.1 University of Wisconsin Madison Pipeline Products & Ongoing Clinical Trials Overview 211
5.98 USGI Medical, Inc. Company Overview 213
5.98.1 USGI Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 213
5.99 Vanderbilt University Company Overview 217
5.99.1 Vanderbilt University Pipeline Products & Ongoing Clinical Trials Overview 217
5.100 Vascular Insights LLC Company Overview 223
5.100.1 Vascular Insights LLC Pipeline Products & Ongoing Clinical Trials Overview 223
5.101 Veol Medical Technologies Company Overview 224
5.101.1 Veol Medical Technologies Pipeline Products & Ongoing Clinical Trials Overview 224
5.102 W.O.M. World Of Medicine GmbH Company Overview 225
5.102.1 W.O.M. World Of Medicine GmbH Pipeline Products & Ongoing Clinical Trials Overview 225
5.103 Weill Cornell Medical College Company Overview 226
5.103.1 Weill Cornell Medical College Pipeline Products & Ongoing Clinical Trials Overview 226
6 Surgical Devices- Recent Developments 227
7 Appendix 362
7.1 Methodology 362
7.2 About GlobalData 364
7.3 Contact Us 365
7.4 Disclaimer 365
【レポート販売概要】
■ タイトル：世界の手術装置開発動向：医療機器パイプライン分析2015■ 英文：Surgical Devices - Medical Devices Pipeline Assessment, 2015
■ 発行日：2016年1月1日
■ 調査会社：GlobalData
■ 商品コード：GDME0137EPD
■ 調査対象地域：グローバル
- 高速液体クロマトグラフィー（HPLC）の世界市場2019-2023About this market Several private and government stakeholders are investing heavily in R&D activities in the healthcare sector. This is mainly to launch products with innovative new technologies in the field of HPLC and to increase the potential of the healthcare industry. Pharmaceutical companies are opting for HPLC for sample testing and analysis. This technique is used to identify potential ing …
- グローバル調理食品市場におけるM&A動向（2014年3月）Synopsis The report provides a review of the mergers and acquisitions (M&As), partnering deals, and agreements entered into by companies active in the global prepared meals market during March 2014. Summary Using this report, dealmakers will effectively gain an insight into deal activity of the global prepared meals market throughout the month. Additionally, the report provides an overview of all …
- 切替スイッチの世界市場2016-2020About Transfer Switch A transfer switch shifts electrical loads or distribution systems between two power sources; it is an essential part of standby or emergency power system. Transfer switches are used in a broad range of applications, such as data centers, hospitals, diagnostic, and other health care centers, factories, warehouses, and other commercial set-ups such as financial institutions. Th …
- 砂糖市場：ブラジルThis report is a comprehensive research of sugar industry in Brazil. The first two chapters of the report feature the country profile by giving general information on Brazil and by thoroughly studying its economic state, (including key macroeconomic indicators and their development trends). The third chapter covers common business procedures in the country: from starting a project to closing a bus …
- Range Resources Corporation：石油・ガスの開発・生産動向及びコスト分析- Q2, 2013Range Resources Corporation Oil & Gas Exploration and Production Operations and Cost Analysis - Q2, 2013 Summary Range Resources Corporation Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an esse …
- 医薬品新興国市場2017-2021About Pharmerging The immense growth potential in pharmerging market has driven large multinational pharmaceutical companies to focus on these regions by pursuing organic as well as in-organic routes. To make in-roads into the new geography, the large players usually take in-organic route through strategic expansion initiatives such as acquisitions and alliances. For instance, in December 2015, As …
- 世界の航空・防衛産業におけるサイバーセキュリティ市場The global aviation & defense cyber security market is projected to grow from USD 39.59 Billion in 2015 to USD 61.85 Billion by 2020, at a CAGR of 9.34% from 2015 to 2020. Factors influencing the growth of this market include increasing popularity of cloud security solutions, emergence of social media, and increasing severity of cyber-attacks. The aerospace and defense industry is becoming highly …
- セキュリティラベルの世界市場：バーコード、無線周波数識別、ホログラフィックMarketsandMarkets projects that the security labels market size by value will grow and reach USD 26.47 Billion by 2020 at a CAGR of 5.13% between 2015 and 2020. The market is growing in accordance with the growth trends of the converting and labeling industries. Factors such as increasing demand from food and beverage industry, demand for retail supplies, consumer durables, and logistics applicati …
- Cachexia：グローバル臨床試験レビューH2, 2013Cachexia Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Cachexia Global Clinical Trials Review, H2, 2013" provides data on the Cachexia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Cachexia. It includes an overview of the trial numbers and their recruitment status as per the site of trial condu …
- 医療分野における人工知能（AI）の世界市場予測（～2022年）According to the forecast provided by MarketsandMarkets, the overall artificial intelligence (AI) in healthcare market was valued at USD 667.1 million in 2016 and is expected to reach USD 7,988.8 million by 2022, at a CAGR of 52.68% between 2017 and 2022. The growth of this market is driven by growing usage of Big Data in healthcare industry, ability of AI to improve patient outcomes, imbalance be …
- 熱交換器の世界市場2017-2021ABSTRACTAbout Heat Exchanger A heat exchanger is a mechanical device that transfers thermal energy from one medium to another. The media are generally separated by a partition to avoid contact between each other. They incorporate fins or corrugations to increase the surface area for enhancing the heat exchange process. Heat exchangers are widely used in industrial applications such as refrigeratio …
- 乳化剤の世界市場2017-2021About emulsifierEmulsifiers are substances that help in creating a smooth mixture of two or more ingredients, which otherwise do not combine easily, and keep them from separating. Emulsifiers are molecules with one oil-friendly and one water-friendly end. The water-friendly end in a food emulsifier is known as the hydrophilic tail and the oil-friendly end is known as the hydrophobic head. Technavi …
- グーグルVS通信キャリア：テレコムとコマースのSWOT分析及び将来（Google vs. Carriers: SWOT Analysis and Future of Telecom and Commerce）It is no secret that Google has expanded beyond its core search business to expand into numerous telecom and ICT areas including applications, commerce, content, and communications. What is less obvious is that there are certain areas that Google is positioned to take significant market share and even potentially dominate. With their own core service offerings becoming increasingly commoditized, t …
- 世界の偽造防止パッケージ市場：技術別、用途別動向及び予測（～2019）The market for anti-counterfeit, anti-tampering and authentication is projected to record a CAGR of 14.1% from 2014 to 2019. The estimation is a result of new products & technologies launches in the industry, with increase in application of anti-counterfeit in different economies. Authentication technology dominates the market in terms of value and market awareness of new target crops such as alfa …
- クラウド分析の世界市場：ビジネスインテリジェンス、データウェアハウス、企業パフォーマンス管理Technavio market research analysts predict the cloud analytics market to grow at a CAGR of approximately 21% until 2020. The cloud analytics market is expanding rapidly as it finds utility in many industries. The emergence of easy implementation of cloud technology and its integration with analytics and BI tools drives this market. To improve customer experience, it is important for organizations …
